{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:10:46Z","timestamp":1791465046045,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T00:00:00Z","timestamp":1727222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-162"],"award-info":[{"award-number":["2022-PUMCH-A-162"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-092"],"award-info":[{"award-number":["2022-PUMCH-B-092"]}]},{"name":"Beijing Municipal Natural Science Foundation","award":["Z210017"],"award-info":[{"award-number":["Z210017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Immunol Res"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12026-024-09545-x","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:24:34Z","timestamp":1727299474000},"page":"1229-1237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Post-translational modification in the pathogenesis of vitiligo"],"prefix":"10.1007","volume":"72","author":[{"given":"Lu","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jindi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,25]]},"reference":[{"key":"9545_CR1","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386:74\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(14)60763-7.","journal-title":"Lancet"},{"key":"9545_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1159\/000506103","volume":"236","author":"C Bergqvist","year":"2020","unstructured":"Bergqvist C, Ezzedine K. Vitiligo: a review. Dermatology. 2020;236:571\u201392. https:\/\/doi.org\/10.1159\/000506103.","journal-title":"Dermatology"},{"key":"9545_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","volume":"45","author":"J Liu","year":"2016","unstructured":"Liu J, Qian C, Cao X. Post-translational modification control of innate immunity. Immunity. 2016;45:15\u201330. https:\/\/doi.org\/10.1016\/j.immuni.2016.06.020.","journal-title":"Immunity"},{"key":"9545_CR4","doi-asserted-by":"publisher","first-page":"965","DOI":"10.2147\/JIR.S339296","volume":"15","author":"L Yang","year":"2022","unstructured":"Yang L, Yan Y. Emerging roles of post-translational modifications in skin diseases: current knowledge, challenges and future perspectives. J Inflamm Res. 2022;15:965\u201375. https:\/\/doi.org\/10.2147\/JIR.S339296.","journal-title":"J Inflamm Res"},{"key":"9545_CR5","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","volume":"6","author":"X Hu","year":"2021","unstructured":"Hu X, Li J, Fu M, Zhao X, Wang W. The JAK\/STAT signaling pathway: from bench to clinic. Signal Transduct Target Ther. 2021;6:402. https:\/\/doi.org\/10.1038\/s41392-021-00791-1.","journal-title":"Signal Transduct Target Ther"},{"key":"9545_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","volume":"40","author":"F Ardito","year":"2017","unstructured":"Ardito F, Giuliani M, Perrone D, Troiano G, Lo ML. The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review). Int J Mol Med. 2017;40:271\u201380. https:\/\/doi.org\/10.3892\/ijmm.2017.3036.","journal-title":"Int J Mol Med"},{"key":"9545_CR7","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3390\/ijms17071144","volume":"17","author":"SAN D\u2019Mello","year":"2016","unstructured":"D\u2019Mello SAN, Finlay GJ, Baguley BC, Askarian-Amiri ME. Signaling pathways in melanogenesis. Int J Mol Sci. 2016;17:1144. https:\/\/doi.org\/10.3390\/ijms17071144.","journal-title":"Int J Mol Sci"},{"key":"9545_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1101\/gad.324657.119","volume":"33","author":"CR Goding","year":"2019","unstructured":"Goding CR, Arnheiter H. MITF\u2014the first 25 years. Genes Dev. 2019;33:983\u20131007. https:\/\/doi.org\/10.1101\/gad.324657.119.","journal-title":"Genes Dev"},{"key":"9545_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/exd.14260","volume":"30","author":"JM Yardman-Frank","year":"2021","unstructured":"Yardman-Frank JM, Fisher DE. Skin pigmentation and its control: from ultraviolet radiation to stem cells. Exp Dermatol. 2021;30:560\u201371. https:\/\/doi.org\/10.1111\/exd.14260.","journal-title":"Exp Dermatol"},{"key":"9545_CR10","doi-asserted-by":"publisher","first-page":"a011148","DOI":"10.1101\/cshperspect.a011148","volume":"4","author":"P Sassone-Corsi","year":"2012","unstructured":"Sassone-Corsi P. The cyclic AMP pathway. Cold Spring Harb Perspect Biol. 2012;4:a011148\u2013a011148. https:\/\/doi.org\/10.1101\/cshperspect.a011148.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9545_CR11","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1093\/emboj\/19.12.2900","volume":"19","author":"R Busca","year":"2000","unstructured":"Busca R. Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes. EMBO J. 2000;19:2900\u201310. https:\/\/doi.org\/10.1093\/emboj\/19.12.2900.","journal-title":"EMBO J"},{"key":"9545_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s42003-022-03049-w","volume":"5","author":"C Estrada","year":"2022","unstructured":"Estrada C, Mirabal-Ortega L, M\u00e9ry L, Dingli F, Besse L, Messaoudi C, et al. MITF activity is regulated by a direct interaction with RAF proteins in melanoma cells. Commun Biol. 2022;5:101. https:\/\/doi.org\/10.1038\/s42003-022-03049-w.","journal-title":"Commun Biol"},{"key":"9545_CR13","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1101\/gad.14.3.301","volume":"14","author":"M Wu","year":"2000","unstructured":"Wu M, Hemesath TJ, Takemoto CM, Horstmann MA, Wells AG, Price ER, et al. c-Kit triggers dual phosphorylations, which couple activation and degradation of the essential melanocyte factor Mi. Genes Dev. 2000;14:301\u201312.","journal-title":"Genes Dev"},{"key":"9545_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/j.1600-0749.2006.00348.x","volume":"19","author":"B Saha","year":"2006","unstructured":"Saha B, Singh SK, Sarkar C, Bera R, Ratha J, Tobin DJ, et al. Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res. 2006;19:595\u2013605. https:\/\/doi.org\/10.1111\/j.1600-0749.2006.00348.x.","journal-title":"Pigment Cell Res"},{"key":"9545_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.06739.x","volume":"153","author":"C-CE Lan","year":"2005","unstructured":"Lan C-CE, Chen G-S, Chiou M-H, Wu C-S, Chang C-H, Yu H-S. FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo: FK506 promotes melanocyte and melanoblast proliferation. Br J Dermatol. 2005;153:498\u2013505. https:\/\/doi.org\/10.1111\/j.1365-2133.2005.06739.x.","journal-title":"Br J Dermatol"},{"key":"9545_CR16","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.jid.2020.12.028","volume":"141","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Duplaine A, Maillard H, Passeron T, Andreu N, Lassalle R, et al. Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study. J Investig Dermatol. 2021;141:1728\u201334. https:\/\/doi.org\/10.1016\/j.jid.2020.12.028.","journal-title":"J Investig Dermatol"},{"key":"9545_CR17","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3892\/ijmm.2018.3861","volume":"42","author":"N Mamat","year":"2018","unstructured":"Mamat N, Lu XY, Kabas M, Aisa HA. Potential anti-vitiligo properties of cynarine extracted from Vernonia anthelmintica (L.) Willd. Int J Mol Med. 2018;42:2665\u201375. https:\/\/doi.org\/10.3892\/ijmm.2018.3861.","journal-title":"Int J Mol Med"},{"key":"9545_CR18","doi-asserted-by":"publisher","unstructured":"Moon SY, Akter K-M, Ahn M-J, Kim KD, Yoo J, Lee J-H, et al. Fraxinol stimulates melanogenesis in B16F10 mouse melanoma cells through CREB\/MITF signaling. Molecules. 2022;27. https:\/\/doi.org\/10.3390\/molecules27051549.","DOI":"10.3390\/molecules27051549"},{"key":"9545_CR19","doi-asserted-by":"publisher","unstructured":"Yoon J-H, Youn K, Jun M. Discovery of pinostrobin as a melanogenic agent in cAMP\/PKA and p38 MAPK signaling pathway. Nutrients. 2022;14. https:\/\/doi.org\/10.3390\/nu14183713.","DOI":"10.3390\/nu14183713"},{"key":"9545_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1111\/ics.12746","volume":"43","author":"M Kim","year":"2021","unstructured":"Kim M, Jeon K, Shin S, Yoon S, Kim H, Kang HY, et al. Melanogenesis-promoting effect of Cirsium japonicum flower extract in vitro and ex vivo. Int J Cosmet Sci. 2021;43:703\u201314. https:\/\/doi.org\/10.1111\/ics.12746.","journal-title":"Int J Cosmet Sci"},{"key":"9545_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.4196\/kjpp.2014.18.4.307","volume":"18","author":"M-J Ahn","year":"2014","unstructured":"Ahn M-J, Hur S-J, Kim E-H, Lee SH, Shin JS, Kim M-K, et al. Scopoletin from Cirsium setidens increases melanin synthesis via CREB phosphorylation in B16F10 cells. Korean J Physiol Pharmacol. 2014;18:307\u201311. https:\/\/doi.org\/10.4196\/kjpp.2014.18.4.307.","journal-title":"Korean J Physiol Pharmacol"},{"key":"9545_CR22","doi-asserted-by":"publisher","first-page":"153941","DOI":"10.1016\/j.phymed.2022.153941","volume":"98","author":"HM Wang","year":"2022","unstructured":"Wang HM, Qu LQ, Ng JPL, Zeng W, Yu L, Song LL, et al. Natural Citrus flavanone 5-demethylnobiletin stimulates melanogenesis through the activation of cAMP\/CREB pathway in B16F10 cells. Phytomedicine. 2022;98:153941. https:\/\/doi.org\/10.1016\/j.phymed.2022.153941.","journal-title":"Phytomedicine"},{"key":"9545_CR23","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.3390\/antiox11061164","volume":"11","author":"KM Moon","year":"2022","unstructured":"Moon KM, Yang J-H, Lee M-K, Kwon E-B, Baek J, Hwang T, et al. Maclurin exhibits antioxidant and anti-tyrosinase activities, suppressing melanogenesis. Antioxidants. 2022;11:1164. https:\/\/doi.org\/10.3390\/antiox11061164.","journal-title":"Antioxidants"},{"key":"9545_CR24","doi-asserted-by":"publisher","first-page":"9827519","DOI":"10.1155\/2019\/9827519","volume":"2019","author":"YS Hwang","year":"2019","unstructured":"Hwang YS, Oh SW, Park S-H, Lee J, Yoo JA, Kwon K, et al. Melanogenic effects of maclurin are mediated through the activation of cAMP\/PKA\/CREB and p38 MAPK\/CREB signaling pathways. Oxid Med Cell Longev. 2019;2019:9827519. https:\/\/doi.org\/10.1155\/2019\/9827519.","journal-title":"Oxid Med Cell Longev"},{"key":"9545_CR25","doi-asserted-by":"publisher","first-page":"3727","DOI":"10.3892\/ijmm.2018.3529","volume":"41","author":"L Yin","year":"2018","unstructured":"Yin L, Pang G, Niu C, Habasi M, Dou J, Aisa HA. A novel psoralen derivative-MPFC enhances melanogenesis via activation of p38 MAPK and PKA signaling pathways in B16 cells. Int J Mol Med. 2018;41:3727\u201335. https:\/\/doi.org\/10.3892\/ijmm.2018.3529.","journal-title":"Int J Mol Med"},{"key":"9545_CR26","doi-asserted-by":"publisher","unstructured":"Zang D, Niu C, Lu X, Aisa HA. A novel furocoumarin derivative, 5-((diethylamino)me-13 thyl)-3-phenyl-7H-furo [3,2-g] chromen-7-one upregulates melanin synthesis via the activation of cAMP\/PKA and MAPKs signal pathway: in vitro and in vivo study. Int J Mol Sci. 2022;23. https:\/\/doi.org\/10.3390\/ijms232214190.","DOI":"10.3390\/ijms232214190"},{"key":"9545_CR27","doi-asserted-by":"publisher","first-page":"790125","DOI":"10.3389\/fimmu.2021.790125","volume":"12","author":"F Qi","year":"2021","unstructured":"Qi F, Liu F, Gao L. Janus kinase inhibitors in the treatment of vitiligo: a review. Front Immunol. 2021;12:790125. https:\/\/doi.org\/10.3389\/fimmu.2021.790125.","journal-title":"Front Immunol"},{"key":"9545_CR28","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jid.2020.04.027","volume":"141","author":"V Azzolino","year":"2021","unstructured":"Azzolino V, Zapata L, Garg M, Gjoni M, Riding RL, Strassner JP, et al. Jak inhibitors reverse vitiligo in mice but do not deplete skin resident memory T cells. J Investig Dermatol. 2021;141:182-184.e1. https:\/\/doi.org\/10.1016\/j.jid.2020.04.027.","journal-title":"J Investig Dermatol"},{"key":"9545_CR29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.freeradbiomed.2019.05.011","volume":"139","author":"X Chen","year":"2019","unstructured":"Chen X, Guo W, Chang Y, Chen J, Kang P, Yi X, et al. Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo. Free Radical Biol Med. 2019;139:80\u201391. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2019.05.011.","journal-title":"Free Radical Biol Med"},{"key":"9545_CR30","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/med.21396","volume":"36","author":"M-C Lu","year":"2016","unstructured":"Lu M-C, Ji J-A, Jiang Z-Y, You Q-D. The Keap1\u2013Nrf2\u2013ARE pathway as a potential preventive and therapeutic target: an update. Med Res Rev. 2016;36:924\u201363. https:\/\/doi.org\/10.1002\/med.21396.","journal-title":"Med Res Rev"},{"key":"9545_CR31","doi-asserted-by":"publisher","first-page":"10941","DOI":"10.1128\/MCB.24.24.10941-10953.2004","volume":"24","author":"DD Zhang","year":"2004","unstructured":"Zhang DD, Lo S-C, Cross JV, Templeton DJ, Hannink M. Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Mol Cell Biol. 2004;24:10941\u201353. https:\/\/doi.org\/10.1128\/MCB.24.24.10941-10953.2004.","journal-title":"Mol Cell Biol"},{"key":"9545_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00403-015-1554-2","volume":"307","author":"A G\u0119gotek","year":"2015","unstructured":"G\u0119gotek A, Skrzydlewska E. The role of transcription factor Nrf2 in skin cells metabolism. Arch Dermatol Res. 2015;307:385\u201396. https:\/\/doi.org\/10.1007\/s00403-015-1554-2.","journal-title":"Arch Dermatol Res"},{"key":"9545_CR33","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1038\/jid.2014.152","volume":"134","author":"Z Jian","year":"2014","unstructured":"Jian Z, Li K, Song P, Zhu G, Zhu L, Cui T, et al. Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. J Invest Dermatol. 2014;134:2221\u201330. https:\/\/doi.org\/10.1038\/jid.2014.152.","journal-title":"J Invest Dermatol"},{"key":"9545_CR34","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.nbd.2015.07.001","volume":"82","author":"LO Iniaghe","year":"2015","unstructured":"Iniaghe LO, Krafft PR, Klebe DW, Omogbai EKI, Zhang JH, Tang J. Dimethyl fumarate confers neuroprotection by casein kinase 2 phosphorylation of Nrf2 in murine intracerebral hemorrhage. Neurobiol Dis. 2015;82:349\u201358. https:\/\/doi.org\/10.1016\/j.nbd.2015.07.001.","journal-title":"Neurobiol Dis"},{"key":"9545_CR35","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.fct.2007.10.006","volume":"46","author":"H-K Na","year":"2008","unstructured":"Na H-K, Surh Y-J. Modulation of Nrf2-mediated antioxidant and detoxifying enzyme induction by the green tea polyphenol EGCG. Food Chem Toxicol. 2008;46:1271\u20138. https:\/\/doi.org\/10.1016\/j.fct.2007.10.006.","journal-title":"Food Chem Toxicol"},{"key":"9545_CR36","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.fitote.2014.08.007","volume":"99","author":"Y Zhu","year":"2014","unstructured":"Zhu Y, Wang S, Lin F, Li Q, Xu A. The therapeutic effects of EGCG on vitiligo. Fitoterapia. 2014;99:243\u201351. https:\/\/doi.org\/10.1016\/j.fitote.2014.08.007.","journal-title":"Fitoterapia"},{"key":"9545_CR37","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1111\/ajd.13612","volume":"62","author":"W Hu","year":"2021","unstructured":"Hu W, Zhang L, Lin F, Lei J, Zhou M, Xu A. Topical epigallocatechin-3-gallate in the treatment of vitiligo. Australas J Dermatol. 2021;62:e404\u20137. https:\/\/doi.org\/10.1111\/ajd.13612.","journal-title":"Australas J Dermatol"},{"key":"9545_CR38","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/ced.15211","volume":"47","author":"W Hu","year":"2022","unstructured":"Hu W, Jin R, Lin F, Lei J, Ma Y, Xu A-E. Repigmentation in two patients with vitiligo on AcEGCG 0.5% cream. Clin Exp Dermatol. 2022;47:1760\u20131. https:\/\/doi.org\/10.1111\/ced.15211.","journal-title":"Clin Exp Dermatol"},{"key":"9545_CR39","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1111\/jocd.14814","volume":"21","author":"S Jalalmanesh","year":"2022","unstructured":"Jalalmanesh S, Mansouri P, Rajabi M, Monji F. Therapeutic effects of turmeric topical cream in vitiligo: a randomized, double-blind, placebo-controlled pilot study. J Cosmetic Dermatol. 2022;21:4454\u201361. https:\/\/doi.org\/10.1111\/jocd.14814.","journal-title":"J Cosmetic Dermatol"},{"key":"9545_CR40","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1089\/pho.2009.2637","volume":"28","author":"P Asawanonda","year":"2010","unstructured":"Asawanonda P, Klahan S-O. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study. Photomed Laser Surg. 2010;28:679\u201384. https:\/\/doi.org\/10.1089\/pho.2009.2637.","journal-title":"Photomed Laser Surg"},{"key":"9545_CR41","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/exd.13350","volume":"26","author":"OA Arowojolu","year":"2017","unstructured":"Arowojolu OA, Orlow SJ, Elbuluk N, Manga P. The nuclear factor (erythroid-derived 2)-like 2 (NRF2) antioxidant response promotes melanocyte viability and reduces toxicity of the vitiligo-inducing phenol monobenzone. Exp Dermatol. 2017;26:637\u201344. https:\/\/doi.org\/10.1111\/exd.13350.","journal-title":"Exp Dermatol"},{"key":"9545_CR42","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.3390\/ijms23063322","volume":"23","author":"L Zeyen","year":"2022","unstructured":"Zeyen L, Seternes OM, Mikkola I. Crosstalk between p38 MAPK and GR signaling. IJMS. 2022;23:3322. https:\/\/doi.org\/10.3390\/ijms23063322.","journal-title":"IJMS"},{"key":"9545_CR43","doi-asserted-by":"publisher","first-page":"4805","DOI":"10.1096\/fj.12-216382","volume":"26","author":"E Ayroldi","year":"2012","unstructured":"Ayroldi E, Cannarile L, Migliorati G, Nocentini G, Delfino DV, Riccardi C. Mechanisms of the anti-inflammatory effects of glucocorticoids: genomic and nongenomic interference with MAPK signaling pathways. FASEB J. 2012;26:4805\u201320. https:\/\/doi.org\/10.1096\/fj.12-216382.","journal-title":"FASEB J"},{"key":"9545_CR44","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1001\/jama.2016.12399","volume":"316","author":"K Ezzedine","year":"2016","unstructured":"Ezzedine K, Whitton M, Pinart M. Interventions for vitiligo. JAMA. 2016;316:1708. https:\/\/doi.org\/10.1001\/jama.2016.12399.","journal-title":"JAMA"},{"key":"9545_CR45","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.semcancer.2010.02.004","volume":"20","author":"A Dey","year":"2010","unstructured":"Dey A, Lane DP, Verma CS. Modulating the p53 pathway. Semin Cancer Biol. 2010;20:3\u20139. https:\/\/doi.org\/10.1016\/j.semcancer.2010.02.004.","journal-title":"Semin Cancer Biol"},{"key":"9545_CR46","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1089\/ars.2009.2779","volume":"13","author":"M Becatti","year":"2010","unstructured":"Becatti M, Prignano F, Fiorillo C, Pescitelli L, Nassi P, Lotti T, et al. The involvement of Smac\/DIABLO, p53, NF-kB, and MAPK pathways in apoptosis of keratinocytes from perilesional vitiligo skin: protective effects of curcumin and capsaicin. Antioxid Redox Signal. 2010;13:1309\u201321. https:\/\/doi.org\/10.1089\/ars.2009.2779.","journal-title":"Antioxid Redox Signal"},{"key":"9545_CR47","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1038\/ni.2744","volume":"14","author":"LK Mackay","year":"2013","unstructured":"Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, Hafon M-L, et al. The developmental pathway for CD103+CD8+ tissue-resident memory T cells of skin. Nat Immunol. 2013;14:1294\u2013301. https:\/\/doi.org\/10.1038\/ni.2744.","journal-title":"Nat Immunol"},{"key":"9545_CR48","doi-asserted-by":"publisher","first-page":"652191","DOI":"10.3389\/fimmu.2021.652191","volume":"12","author":"GE Ryan","year":"2021","unstructured":"Ryan GE, Harris JE, Richmond JM. Resident memory T cells in autoimmune skin diseases. Front Immunol. 2021;12:652191. https:\/\/doi.org\/10.3389\/fimmu.2021.652191.","journal-title":"Front Immunol"},{"key":"9545_CR49","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","volume":"46","author":"S Cheuk","year":"2017","unstructured":"Cheuk S, Schlums H, Gallais S\u00e9r\u00e9zal I, Martini E, Chiang SC, Marquardt N, et al. CD49a expression defines tissue-resident CD8 + T cells poised for cytotoxic function in human skin. Immunity. 2017;46:287\u2013300. https:\/\/doi.org\/10.1016\/j.immuni.2017.01.009.","journal-title":"Immunity"},{"key":"9545_CR50","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/exd.13879","volume":"28","author":"K Boniface","year":"2019","unstructured":"Boniface K, Seneschal J. Vitiligo as a skin memory disease: the need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells. Exp Dermatol. 2019;28:656\u201361. https:\/\/doi.org\/10.1111\/exd.13879.","journal-title":"Exp Dermatol"},{"key":"9545_CR51","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/pcmr.12803","volume":"32","author":"M Willemsen","year":"2019","unstructured":"Willemsen M, Linkut\u0117 R, Luiten RM, Matos TR. Skin-resident memory T cells as a potential new therapeutic target in vitiligo and melanoma. Pigment Cell Melanoma Res. 2019;32:612\u201322. https:\/\/doi.org\/10.1111\/pcmr.12803.","journal-title":"Pigment Cell Melanoma Res"},{"key":"9545_CR52","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1172\/JCI16432","volume":"111","author":"I Tiede","year":"2003","unstructured":"Tiede I, Fritz G, Strand S, Poppe D, Dvorsky R, Strand D, et al. CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4+ T lymphocytes. J Clin Invest. 2003;111:1133\u201345. https:\/\/doi.org\/10.1172\/JCI16432.","journal-title":"J Clin Invest"},{"key":"9545_CR53","doi-asserted-by":"publisher","first-page":"640","DOI":"10.4049\/jimmunol.176.1.640","volume":"176","author":"D Poppe","year":"2006","unstructured":"Poppe D, Tiede I, Fritz G, Becker C, Bartsch B, Wirtz S, et al. Azathioprine suppresses ezrin-radixin-moesin-dependent T Cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins. J Immunol. 2006;176:640\u201351. https:\/\/doi.org\/10.4049\/jimmunol.176.1.640.","journal-title":"J Immunol"},{"key":"9545_CR54","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.jaad.2019.03.025","volume":"85","author":"S Patra","year":"2021","unstructured":"Patra S, Khaitan BK, Sharma VK, Khanna N. A randomized comparative study of the effect of betamethasone oral mini-pulse therapy versus oral azathioprine in progressive nonsegmental vitiligo. J Am Acad Dermatol. 2021;85:728\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2019.03.025.","journal-title":"J Am Acad Dermatol"},{"key":"9545_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.4103\/ijd.ijd_865_22","volume":"68","author":"S Jawade","year":"2023","unstructured":"Jawade S, Saoji V, Madke B, Singh A. Comparison of oral azathioprine and oral mini pulse steroid in the treatment of vitiligo: an open-label randomized controlled trial. Indian J Dermatol. 2023;68:591\u20137. https:\/\/doi.org\/10.4103\/ijd.ijd_865_22.","journal-title":"Indian J Dermatol"},{"key":"9545_CR56","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/s41580-018-0081-3","volume":"20","author":"T Narita","year":"2019","unstructured":"Narita T, Weinert BT, Choudhary C. Functions and mechanisms of non-histone protein acetylation. Nat Rev Mol Cell Biol. 2019;20:156\u201374. https:\/\/doi.org\/10.1038\/s41580-018-0081-3.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9545_CR57","doi-asserted-by":"publisher","first-page":"831168","DOI":"10.3389\/fimmu.2022.831168","volume":"13","author":"Y Yang","year":"2022","unstructured":"Yang Y, Liu Y, Wang Y, Chao Y, Zhang J, Jia Y, et al. Regulation of SIRT1 and its roles in inflammation. Front Immunol. 2022;13:831168. https:\/\/doi.org\/10.3389\/fimmu.2022.831168.","journal-title":"Front Immunol"},{"key":"9545_CR58","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/jcmm.12206","volume":"18","author":"M Becatti","year":"2014","unstructured":"Becatti M, Fiorillo C, Barygina V, Cecchi C, Lotti T, Prignano F, et al. SIRT1 regulates MAPK pathways in vitiligo skin: insight into the molecular pathways of cell survival. J Cell Mol Med. 2014;18:514\u201329. https:\/\/doi.org\/10.1111\/jcmm.12206.","journal-title":"J Cell Mol Med"},{"key":"9545_CR59","doi-asserted-by":"publisher","first-page":"3632","DOI":"10.1111\/j.1582-4934.2008.00453.x","volume":"13","author":"C Cao","year":"2009","unstructured":"Cao C, Lu S, Kivlin R, Wallin B, Card E, Bagdasarian A, et al. SIRT1 confers protection against UVB- and H2O2-induced cell death via modulation of p53 and JNK in cultured skin keratinocytes. J Cell Mol Medi. 2009;13:3632\u201343. https:\/\/doi.org\/10.1111\/j.1582-4934.2008.00453.x.","journal-title":"J Cell Mol Medi"},{"key":"9545_CR60","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/bjd.19666","volume":"184","author":"HD Brahmbhatt","year":"2021","unstructured":"Brahmbhatt HD, Gupta R, Gupta A, Rastogi S, Misri R, Mobeen A, et al. The long noncoding RNA MALAT1 suppresses miR-211 to confer protection from ultraviolet-mediated DNA damage in vitiligo epidermis by upregulating sirtuin 1*. Br J Dermatol. 2021;184:1132\u201342. https:\/\/doi.org\/10.1111\/bjd.19666.","journal-title":"Br J Dermatol"},{"key":"9545_CR61","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1093\/nar\/gkab161","volume":"49","author":"Z Diao","year":"2021","unstructured":"Diao Z, Ji Q, Wu Z, Zhang W, Cai Y, Wang Z, et al. SIRT3 consolidates heterochromatin and counteracts senescence. Nucleic Acids Res. 2021;49:4203\u201319. https:\/\/doi.org\/10.1093\/nar\/gkab161.","journal-title":"Nucleic Acids Res"},{"key":"9545_CR62","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.7150\/thno.30398","volume":"9","author":"X Yi","year":"2019","unstructured":"Yi X, Guo W, Shi Q, Yang Y, Zhang W, Chen X, et al. SIRT3-dependent mitochondrial dynamics remodeling contributes to oxidative stress-induced melanocyte degeneration in vitiligo. Theranostics. 2019;9:1614\u201333. https:\/\/doi.org\/10.7150\/thno.30398.","journal-title":"Theranostics"},{"key":"9545_CR63","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/1346-8138.16634","volume":"50","author":"X-J Nie","year":"2023","unstructured":"Nie X-J, Hao B-Z, Zhang B-L, Li Y-Y. GATA3 ameliorates melanocyte injuries in vitiligo through SIRT3-mediated HMGB1 deacetylation. J Dermatol. 2023;50:472\u201384. https:\/\/doi.org\/10.1111\/1346-8138.16634.","journal-title":"J Dermatol"},{"key":"9545_CR64","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic D, Vucic D, Dikic I. Ubiquitination in disease pathogenesis and treatment. Nat Med. 2014;20:1242\u201353. https:\/\/doi.org\/10.1038\/nm.3739.","journal-title":"Nat Med"},{"key":"9545_CR65","doi-asserted-by":"publisher","unstructured":"Yuan X, Meng D, Cao P, Sun L, Pang Y, Li Y, et al. Identification of pathogenic genes and transcription factors in vitiligo. Dermatol Ther. 2019;32. https:\/\/doi.org\/10.1111\/dth.13025.","DOI":"10.1111\/dth.13025"},{"key":"9545_CR66","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jdermsci.2016.07.006","volume":"84","author":"P Wang","year":"2016","unstructured":"Wang P, Li Y, Nie H, Zhang X, Shao Q, Hou X, et al. The changes of gene expression profiling between segmental vitiligo, generalized vitiligo and healthy individual. J Dermatol Sci. 2016;84:40\u20139. https:\/\/doi.org\/10.1016\/j.jdermsci.2016.07.006.","journal-title":"J Dermatol Sci"},{"key":"9545_CR67","doi-asserted-by":"publisher","first-page":"663091","DOI":"10.3389\/fgene.2021.663091","volume":"12","author":"L Li","year":"2021","unstructured":"Li L, Xie Z, Qian X, Wang T, Jiang M, Qin J, et al. Identification of a potentially functional circRNA-miRNA-mRNA regulatory network in melanocytes for investigating pathogenesis of vitiligo. Front Genet. 2021;12:663091. https:\/\/doi.org\/10.3389\/fgene.2021.663091.","journal-title":"Front Genet"},{"key":"9545_CR68","doi-asserted-by":"publisher","first-page":"866703","DOI":"10.3389\/fimmu.2022.866703","volume":"13","author":"K Fukuda","year":"2022","unstructured":"Fukuda K. Networks of CD8+ T cell response activation in melanoma and vitiligo. Front Immunol. 2022;13:866703. https:\/\/doi.org\/10.3389\/fimmu.2022.866703.","journal-title":"Front Immunol"},{"key":"9545_CR69","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1111\/bjd.15391","volume":"178","author":"P Dani","year":"2018","unstructured":"Dani P, Patnaik N, Singh A, Jaiswal A, Agrawal B, Kumar AA, et al. Association and expression of the antigen-processing gene PSMB8, coding for low-molecular-mass protease 7, with vitiligo in North India: case-control study. Br J Dermatol. 2018;178:482\u201391. https:\/\/doi.org\/10.1111\/bjd.15391.","journal-title":"Br J Dermatol"},{"key":"9545_CR70","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1111\/exd.12184","volume":"22","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Wang S, Xu A. A mouse model of vitiligo induced by monobenzone. Exp Dermatol. 2013;22:499\u2013501. https:\/\/doi.org\/10.1111\/exd.12184.","journal-title":"Exp Dermatol"},{"key":"9545_CR71","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/jid.2011.16","volume":"131","author":"JG van den Boorn","year":"2011","unstructured":"van den Boorn JG, Picavet DI, van Swieten PF, van Veen HA, Konijnenberg D, van Veelen PA, et al. Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy. J Invest Dermatol. 2011;131:1240\u201351. https:\/\/doi.org\/10.1038\/jid.2011.16.","journal-title":"J Invest Dermatol"},{"key":"9545_CR72","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1111\/febs.15319","volume":"287","author":"AB Celen","year":"2020","unstructured":"Celen AB, Sahin U. Sumoylation on its 25th anniversary: mechanisms, pathology, and emerging concepts. FEBS J. 2020;287:3110\u201340. https:\/\/doi.org\/10.1111\/febs.15319.","journal-title":"FEBS J"},{"key":"9545_CR73","doi-asserted-by":"publisher","first-page":"4249","DOI":"10.1242\/jcs.050542","volume":"122","author":"Y Wang","year":"2009","unstructured":"Wang Y, Dasso M. SUMOylation and deSUMOylation at a glance. J Cell Sci. 2009;122:4249\u201352. https:\/\/doi.org\/10.1242\/jcs.050542.","journal-title":"J Cell Sci"},{"key":"9545_CR74","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.3892\/mmr.2018.9299","volume":"18","author":"M Zhou","year":"2018","unstructured":"Zhou M, Lin F, Xu W, Jin R, Xu A. Decreased SUMOylation of the retinoblastoma protein in keratinocytes during the pathogenesis of vitiligo. Mol Med Rep. 2018;18:3469\u201375. https:\/\/doi.org\/10.3892\/mmr.2018.9299.","journal-title":"Mol Med Rep"},{"key":"9545_CR75","doi-asserted-by":"publisher","first-page":"R229","DOI":"10.1016\/j.cub.2019.01.003","volume":"29","author":"J Eichler","year":"2019","unstructured":"Eichler J. Protein glycosylation. Curr Biol. 2019;29:R229\u201331. https:\/\/doi.org\/10.1016\/j.cub.2019.01.003.","journal-title":"Curr Biol"},{"key":"9545_CR76","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2133.2003.05577.x","volume":"149","author":"G Carlie","year":"2003","unstructured":"Carlie G, Ntusi NBA, Hulley PA, Kidson SH. KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro. Br J Dermatol. 2003;149:707\u201317. https:\/\/doi.org\/10.1046\/j.1365-2133.2003.05577.x.","journal-title":"Br J Dermatol"}],"container-title":["Immunologic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12026-024-09545-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12026-024-09545-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,4]],"date-time":"2024-12-04T05:08:26Z","timestamp":1733288906000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12026-024-09545-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":76,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9545"],"URL":"https:\/\/doi.org\/10.1007\/s12026-024-09545-x","relation":{},"ISSN":["0257-277X","1559-0755"],"issn-type":[{"value":"0257-277X","type":"print"},{"value":"1559-0755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,25]]},"assertion":[{"value":"9 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}